HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease
Open Access
- 10 March 2025
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 13 (3) , 683
Abstract
Iron overload can lead to increased deposition of iron and cause organ damage in the liver, the pancreas, the heart and the synovium. Iron overload disorders are due to either genetic or acquired abnormalities such as excess transfusions or chronic liver diseases. The most common genetic disease of iron deposition is classic hemochromatosis (HH) type 1, which is caused by mutations of HFE. Other rare forms of HH include type 2A with mutations at the gene hemojuvelin or type 2B with mutations in HAMP that encodes hepcidin. HH type 3, is caused by mutations of the gene that encodes transferrin receptor 2. Mutations of SLC40A1 which encodes ferroportin cause either HH type 4A or HH type 4B. In the present review, an overview of iron metabolism including absorption by enterocytes and regulation of iron by macrophages, liver sinusoidal endothelial cells (LSECs) and hepatocyte production of hepcidin is presented. Hereditary Hemochromatosis and the current pathogenetic model are analyzed. Finally, a new hypothesis based on published data was suggested. The Kupffer cell is the primary defect in HFE hemochromatosis (and possibly in types 2 and 3), while the hepcidin-relative deficiency, which is the common underlying abnormality in the three types of HH, is a secondary consequence.Keywords
This publication has 324 references indexed in Scilit:
- Fibrinogen‐like 1: A hepatokine linking liver physiology to hematologyHemaSphere, 2024
- FKBP12 inhibits hepcidin expression by modulating BMP receptors interaction and ligand responsiveness in hepatocytesAmerican Journal of Hematology, 2023
- Functional role of endothelial transferrin receptor 1 in iron sensing and homeostasisAmerican Journal of Hematology, 2022
- Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questionsDevelopmental Dynamics, 2021
- Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesisAmerican Journal of Hematology, 2018
- Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6American Journal of Hematology, 2017
- Identification of new BMP6 pro‐peptide mutations in patients with iron overloadAmerican Journal of Hematology, 2017
- Erythroferrone and matriptase‐2 independently regulate hepcidin expressionAmerican Journal of Hematology, 2017
- High Frequency of Chimerism in Transplanted LiversHepatology, 2003
- Prevalence of C282Y and H63D Mutations in the Hemochromatosis (HFE) Gene in the United StatesJAMA, 2001